Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
38 hedge funds and large institutions have $45.6M invested in Histogen Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 20 closing their positions.
171% more call options, than puts
Call options by funds: $482K | Put options by funds: $178K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $52M → $45.6M (-$6.41M)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
21% less funds holding
Funds holding: 48 → 38 (-10)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
+$1.3M |
| 2 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$914K |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$705K |
| 4 |
Jane Street
New York
|
+$625K |
| 5 |
ARC
Absolute Return Capital
Boston,
Massachusetts
|
+$544K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$6.91M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$1.79M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$1.22M |
| 4 |
JC
JBF Capital
Aspen,
Colorado
|
-$1.21M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$979K |
HSTO Hedge Fund Activity: Q2 2014 in Review
38 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2014, worth a combined $45.6M — down 12% from $52M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of HSTO and 10 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Axa, adding an estimated $1.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $6.91M sold.
- 38 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2014, down from 48 in Q1 2014.
- Funds reported $45.6M of Histogen Inc. Common Stock stock for Q2 2014, down 12% quarter-over-quarter.
- 10 funds opened new Histogen Inc. Common Stock positions in Q2 2014 and 20 closed out, a net change of -10 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2014 was Axa, an estimated $1.3M added.
- The largest Histogen Inc. Common Stock seller in Q2 2014 was Jennison Associates, an estimated $6.91M sold.
Based on aggregated 13F filings for Q2 2014.